EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells

Cees-Jan Oostwouder, Karin Vos, Mathijs R. Merkus, Casper S. Tolsma, Max B. de Smit, Thomas Telders, David F. A. van Deursen, Femke H. Bouwman, Jos W. R. Twisk, Markus W. Hollmann, Coenraad K. van Kalken

Frontiers in Pharmacology · 03.11.2026 · 17

DOI: 10.3389/fphar.2026.1900376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.11.2026. Verfasst von Cees-Jan Oostwouder und 10 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Local anesthetics are canonically used for analgesia and anti-arrhythmic therapy, but increasing evidence indicates additional anti-inflammatory properties, including modulation of purinergic signalling. A recent retrospective observational cohort study indicated that subcutaneous lidocaine–Hydroxypropyl-β-cyclodextrin (HP-β-CD) was associated with sustained improvements in quality of life in patients with neuropathic pain in post-COVID, but the underlying mechanism remains to be established. The aim of this study was to determine whether lidocaine and articaine, alone or in combination with HP-β-CD, modulate in vitro immune cell activation and cytokine secretion in human peripheral blood mononuclear cells (PBMCs).

Methods

PBMCs were stimulated using phytohemagglutinin (PHA), lipopolysaccharide (LPS), or LPS combined with adenosine triphosphate (ATP) to engage P2X-associated inflammatory pathways, and compounds were applied both prior to and following stimulation. Cytokine secretion was quantified using a 13-plex immunoassay and cell activation was assessed by flow cytometry.

Results

Lidocaine-containing formulations attenuated cytokine secretion most prominently under conditions engaging ATP-dependent signaling, reducing interleukin-1β and interferon-α2, with interleukin-1β suppression being the most consistent effect across stimulation conditions. Articaine showed less consistent immunomodulatory effects than lidocaine, which may reflect its previously reported lack of purinergic receptor inhibition, while HP-β-CD alone did not influence immune activation or cytokine release under any condition.

Discussion

Together, these findings show that lidocaine-containing treatments can modulate cytokine responses in human PBMCs, particularly under LPS with ATP stimulation. These findings identify lidocaine as a modulator of ATP-dependent inflammatory signaling.

Zitieren

APA

Oostwouder, C., Vos, K., Merkus, M. R., Tolsma, C. S., Smit, M. B. D., Telders, T., Deursen, D. F. A. V., Bouwman, F. H., Twisk, J. W. R., Hollmann, M. W., & Kalken, C. K. V. (2026). Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1900376

Vancouver

Oostwouder C, Vos K, Merkus MR, Tolsma CS, Smit MBD, Telders T, et al. Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1900376

BibTeX
@article{Oostwouder2026,
  author = {Oostwouder, Cees-Jan and Vos, Karin and Merkus, Mathijs R. and Tolsma, Casper S. and Smit, Max B. de and Telders, Thomas and Deursen, David F. A. van and Bouwman, Femke H. and Twisk, Jos W. R. and Hollmann, Markus W. and Kalken, Coenraad K. van},
  title = {Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1900376}
}
Kostenlos starten →